三联疗法治疗幽门螺杆菌相关性胃炎前后中医证型分析
|
摘要
研究背景:
幽门螺杆菌(HP)相关性胃炎为临床常见病,多发病,易反复发作,难于治愈。目前已公认,HP是慢性胃炎、消化性溃疡的重要致病因子,是胃癌发生的启动因子之一。国内外对HP相关性胃炎的治疗常规采用联合用药的方案,常用的有质子泵抑制剂加两种抗生素或铋剂加两种抗生素组成的三联疗法。目前对于HP相关性胃炎的中医研究多局限在中药或中成药抗HP疗效观察上,而对HP相关性胃炎中医证型分布及现代医学三联或四联疗法治疗前后中医证型变化规律则无相关研究。为了更好地在西药治疗HP时或治疗后使用中药,减少副作用及复发率,我们观察三联疗法治疗HP相关性胃炎前后证型变化。
目的:
观察三联治疗疗法治疗HP相关性胃炎治疗前后患者中医证型的变化,探讨三联治疗疗法对患者中医证型变化的影响。
方法:通
过病历资料的收集,将符合纳入标准的HP相关性胃炎患者按标准治疗方案予三联抗HP治疗,7天为1疗程。分别治疗前、治疗后记录患者中医四诊信息,进行中医辨证分型。设定相应的证型统计表,建立证候四诊指标信息数据库,并通过统计软件统计分析研究三联疗法治疗前后患者症候分布规律及变化。计数资料的比较采用X~2检验,计量资料采用t检验(或秩和检验)。软件使用统计包(SPSS version 15.0 for XP),以P＜0.05表示有显著性意义。
结果
1、广州及周边地区幽门螺杆菌相关性胃炎中医证型分布规律为:脾胃虚弱型:24%;肝胃不和型:13.5%;胃阴亏虚型:6.3%;脾胃湿热型:42.7%;冒络瘀血型:5.2%;脾胃虚寒型:4.2%;其它证型4.2%。
2、脾胃虚弱型、脾胃湿热型三联疗法治疗前后变化具有显著性差异,脾胃虚弱型患者治疗后较治疗前增多,脾胃湿热型患者治疗后较治疗前减少,具有统计学意义。
3、三联疗法治疗后,实证证型较治疗前减少,虚证证型较治疗前增多,其结果具有统计学意义。
结论:
三联疗法治疗幽门螺杆菌相关性胃炎治疗前后中医证型发生了变化,具有从实证向虚证转变的规律,三联治疗疗法治疗后患者脾虚证型较治疗前增多。
Background:
Helicobacter pylori-associated gastritis(HpAG)is a common and frequently-occurring disease,it is easy to recur and hard to healing.Up to date,H.pylori infection was accepted as the major pathogenic factor of chronic active and peptic ulcers;Infection of H.pylori was related to the occurrence of gastric adenocarcinoma.The received method is triple therapy base on antibiotics and PPI/RBC.In recent years,the traditional Chinese medicine has made many researches on the HpAG syndrome-type and anti-Hp.There have very important significance to research the rule of the changes in traditional Chinese medicine type of syndrome of HpAG after triple therapy.
Objective:
Research the changes in traditional Chinese medicine types of syndromes of HpAG before and after triple therapy,and to analyze the influence of triple therapy to HpAG on traditional Chinese medicine types of syndromes.
Methods:
Through medical record material collection,we will conform to the HpAG patient which will bring into line with the standard.Treat according to the standard treatment,7 days for a course of treatment.Record patient' s symptom through four diagnostic methods and differentiate syndromes,hypothesis and establish corresponding type of syndrome statistical table,the enumeration data comparison to use the X~2 examination,the rank data uses the non-parameter statistical method,the measurement data uses the t examination or rank sum test,Software use statistics package(SPSS Version 15.0 for XP),which 0.05 expression has the significance.
Results:
1.Syndromes distribution of HpAG in Guangzhou and its peripheral regions is following:syndrome of spleen deficiency:24.0%(23/96);syndrome of stagnation of liver qi:13.5%(13/96);syndrome of yin deficiency:6.3%(6/96); syndrome of dampness-heat:42.7%(41/96);syndrome of static blood:5.2% (5/96);syndrome of deficient cold:4.2%(4/96);others syndrome:4.2%(4/96).
2.The changes of syndrome of spleen deficiency and syndrome of dampness-heat before and after triple therapy were significantly different. Syndrome of spleen deficiency had significantly aggravated after triple therapy.
3.The excess syndrome had significant increased and the deficiency syndrome had significant decreased after triple therapy.
Conclusion:
Traditional Chinese medicine types of syndromes of HpAG had changed after triple therapy and the syndrome evolution regularity transfers from the excess syndrome to the deficiency syndrome.Syndrome of spleen deficiency had significantly aggravated after triple therapy.
幽门螺杆菌(HP)相关性胃炎为临床常见病,多发病,易反复发作,难于治愈。目前已公认,HP是慢性胃炎、消化性溃疡的重要致病因子,是胃癌发生的启动因子之一。国内外对HP相关性胃炎的治疗常规采用联合用药的方案,常用的有质子泵抑制剂加两种抗生素或铋剂加两种抗生素组成的三联疗法。目前对于HP相关性胃炎的中医研究多局限在中药或中成药抗HP疗效观察上,而对HP相关性胃炎中医证型分布及现代医学三联或四联疗法治疗前后中医证型变化规律则无相关研究。为了更好地在西药治疗HP时或治疗后使用中药,减少副作用及复发率,我们观察三联疗法治疗HP相关性胃炎前后证型变化。
目的:
观察三联治疗疗法治疗HP相关性胃炎治疗前后患者中医证型的变化,探讨三联治疗疗法对患者中医证型变化的影响。
方法:通
过病历资料的收集,将符合纳入标准的HP相关性胃炎患者按标准治疗方案予三联抗HP治疗,7天为1疗程。分别治疗前、治疗后记录患者中医四诊信息,进行中医辨证分型。设定相应的证型统计表,建立证候四诊指标信息数据库,并通过统计软件统计分析研究三联疗法治疗前后患者症候分布规律及变化。计数资料的比较采用X~2检验,计量资料采用t检验(或秩和检验)。软件使用统计包(SPSS version 15.0 for XP),以P＜0.05表示有显著性意义。
结果
1、广州及周边地区幽门螺杆菌相关性胃炎中医证型分布规律为:脾胃虚弱型:24%;肝胃不和型:13.5%;胃阴亏虚型:6.3%;脾胃湿热型:42.7%;冒络瘀血型:5.2%;脾胃虚寒型:4.2%;其它证型4.2%。
2、脾胃虚弱型、脾胃湿热型三联疗法治疗前后变化具有显著性差异,脾胃虚弱型患者治疗后较治疗前增多,脾胃湿热型患者治疗后较治疗前减少,具有统计学意义。
3、三联疗法治疗后,实证证型较治疗前减少,虚证证型较治疗前增多,其结果具有统计学意义。
结论:
三联疗法治疗幽门螺杆菌相关性胃炎治疗前后中医证型发生了变化,具有从实证向虚证转变的规律,三联治疗疗法治疗后患者脾虚证型较治疗前增多。
Background:
Helicobacter pylori-associated gastritis(HpAG)is a common and frequently-occurring disease,it is easy to recur and hard to healing.Up to date,H.pylori infection was accepted as the major pathogenic factor of chronic active and peptic ulcers;Infection of H.pylori was related to the occurrence of gastric adenocarcinoma.The received method is triple therapy base on antibiotics and PPI/RBC.In recent years,the traditional Chinese medicine has made many researches on the HpAG syndrome-type and anti-Hp.There have very important significance to research the rule of the changes in traditional Chinese medicine type of syndrome of HpAG after triple therapy.
Objective:
Research the changes in traditional Chinese medicine types of syndromes of HpAG before and after triple therapy,and to analyze the influence of triple therapy to HpAG on traditional Chinese medicine types of syndromes.
Methods:
Through medical record material collection,we will conform to the HpAG patient which will bring into line with the standard.Treat according to the standard treatment,7 days for a course of treatment.Record patient' s symptom through four diagnostic methods and differentiate syndromes,hypothesis and establish corresponding type of syndrome statistical table,the enumeration data comparison to use the X~2 examination,the rank data uses the non-parameter statistical method,the measurement data uses the t examination or rank sum test,Software use statistics package(SPSS Version 15.0 for XP),which 0.05 expression has the significance.
Results:
1.Syndromes distribution of HpAG in Guangzhou and its peripheral regions is following:syndrome of spleen deficiency:24.0%(23/96);syndrome of stagnation of liver qi:13.5%(13/96);syndrome of yin deficiency:6.3%(6/96); syndrome of dampness-heat:42.7%(41/96);syndrome of static blood:5.2% (5/96);syndrome of deficient cold:4.2%(4/96);others syndrome:4.2%(4/96).
2.The changes of syndrome of spleen deficiency and syndrome of dampness-heat before and after triple therapy were significantly different. Syndrome of spleen deficiency had significantly aggravated after triple therapy.
3.The excess syndrome had significant increased and the deficiency syndrome had significant decreased after triple therapy.
Conclusion:
Traditional Chinese medicine types of syndromes of HpAG had changed after triple therapy and the syndrome evolution regularity transfers from the excess syndrome to the deficiency syndrome.Syndrome of spleen deficiency had significantly aggravated after triple therapy.
引文
[1]张万岱,徐智民等.幽门螺杆菌研究的现状与展望.中国中西医结合消化杂志,2001:9(6):375
[2]林三仁.幽门螺杆菌与胃癌的关系.中华消化杂志,2002;22:302
[3]蔡锦莲,黄明河等.慢性胃痛证幽门螺杆菌感染的观察.中国中西医结合脾胃杂志,2000:8(5):319-320
[4]王立,赵荣莱等.慢性胃炎、消化性溃疡中医证型与幽门螺杆菌的关系.中国中西医结合脾胃杂志,1995;3(1):27-28
[5]危北海.慢性胃炎的诊断.中西医结合杂志,1990:10(5):265
[6]朱慧芳,厉兰娜等.幽门螺杆菌感染与慢性胃炎215例临床分析.中国中西医结合脾胃杂志,1996;4(4):244
[7]朱宁,张万岱等.脾虚证各型患者与幽门螺杆菌感染情况的检测.中国中西医结合脾胃杂志,1995;3(2):70-71
[8]张琳,杨连文等.幽门螺杆菌与慢性萎缩性胃炎发病关系及防治研究.中国中西医结合杂志,1992;12(9):521
[9]陈云芝,项柏康等.胃乐汤治疗慢性胃病伴幽门螺杆菌感染的疗效观察.新中医,1995:27(9):21
[10]邓世荣.槟榔治疗幽门螺杆菌感染的临床观察.中医杂志,1993;34(10):605
[11]王绪霖,缴稳玲等.抑制幽门螺旋菌中药的初步筛选.中国中西医结合杂志,1994:14(9):534-536
[12]吴静,王克霞.中药制剂体外抑杀幽门螺杆菌的研究进展.时珍国医国药,2006;17(4):632
[13]朱传伟,朱鸿铭.鲁胃方治疗幽门螺杆菌相关性胃炎37例.山东中医杂志,1997;16(5):208
[14]简军.半夏泻心汤治疗幽门螺杆菌相关性胃炎60例.河南中医,2005;25(1):18
[15]王美林.黄连清胃汤治疗幽门螺杆菌相关性胃炎临床观察.中医药学刊,2005;23(8):1539
[16]李贵贤,陈国忠等.健胃口服液治疗幽门螺杆菌相关性胃炎临床观察.中国中西医结合消化杂志,2004;12(5):274-275
[17]白光.清幽汤加味治疗幽门螺杆菌相关性胃炎临床观察.辽宁中医杂志,2005;32(1):42
[18]郑学宝,尚文燔.疏肝健脾法治疗幽门螺杆菌相关性胃炎44例临床观察.新中医, 1999:31(6):14
[19]姚洁明,卫利平.60例幽门螺杆菌相关性胃炎的疗效分析.上海中医药杂志,1992:2(11):15-16
[20]吴演,柴可夫等.清热益胃汤治疗幽门螺杆菌相关性胃炎31例.浙江中医杂志,1990:26(10):440
[21]曹勤,孙钰等.肠胃清抗幽门螺杆菌感染的临床前瞻性研究.中华消化杂志,2000:20(1):70
[22]姜国平,盛建文等.安中饮治疗幽门螺杆菌相关性胃炎30例.世界华人消化杂志,2004:12(12):2919
[23]王丙信,李进银等.中西医结合治疗幽门螺杆菌相关胃炎81例.中国中西医结合脾胃杂志,1998;6(4):215-216
[24]姚希贤,蒋树林.灭幽门螺杆菌胶囊结合低剂量标准三联法治疗慢性胃炎作用的研究.中国中西医结合脾胃杂志,1997;5(3):131-133
[25]刘汶,王斌等.铋剂与中药二联治疗慢性浅表性胃炎并幽门螺杆菌感染.中国中西医结合脾胃杂志,1999;7(2):102
[26]汪红兵,张声生等.健脾清化法联合西药治疗幽门螺杆菌相关性胃炎34例.中国中西医结合消化杂志,2006;14(6):390
[27]张万怠,徐智民等.幽门螺杆菌研究的现状与展望.中国中西医结合消化杂志,2001:9(6):375。
[28]Alm RA,et al.Genome-sequence comparison of two unrelated isolates of the human gastric pathogen Helicobacter pylori[J].Nature,1999;397:176-180
[29]胡品津,胡伏莲.中华医学会第四次全国幽门螺杆菌学术会议纪要.中华消化杂志,2005:25(11):698
[30]Xiang ZY,Censini S,Bayeli PF,Telford JL,Figura N,Rappuole R et al.Analysis of expression of CagA and VacA virulence factors in 43 strains of Helicobacter pylori reveals that clinical isolates can be divided into two major types and that CagA is not necessary for expression of the vacuolating cytotoxin[J].Infect Immun,1995;63(1):94-98
[31]姚希贤.治疗幽门螺杆菌的研究进展.新消化病学杂志,1999;10(5):267-268
[32]单蕴,许树长,叶元康.幽门螺杆菌抗生素耐药率分析.同济大学学报(医学版),2004:25(1):30-32
[33]陈翠萍,关于幽门螺杆菌疫苗及其相关性研究的报告.微生物学与免疫学进展,2003:31(4):91-93
[34]危北海.近年来消化系统疾病若干问题研究进展及其对中医、中西医结合的挑战 和启示.中华消化杂志,2000;20(4):221
[35]常可敏.中西医综合治疗幽门螺杆菌相关性胃炎106例临床观察.实用中西医结合杂志,1998;11(6):527
[36]王胜功,周玉中.中西医结合治疗慢性胃炎疗效观察.河北中医,2000;22(7):537-538
[37]胡伏莲.幽门螺杆菌感染与上胃肠道疾病.临床内科杂志,2003;20(2):57-59
[38]中华医学会消化病学分会.幽门螺杆菌若干问题的共识意见.中华消化杂志,2000:20(2):117-118
[39]李瑜元.慢性胃炎病因学的新进展.新医学,1998;29(5):230
[40]刘炯.幽门螺杆菌基因组及基因多态性与疾病.见:刘文忠主编.幽门螺杆菌研究进展.上海:上海科学技术文献出版社,2001:1-29
[41]张静,丁士刚,林三仁等.幽门螺杆菌根除治疗方案比较.临床荟萃,2006;21(22):1600
[42]李平,张军会,周华等.蜂胶左金胃三联治疗幽门螺杆菌相关性胃炎的临床研究.云南中医学院学报,2006;29(4):17-18
[43]中华医学会消化病学分会 幽门螺杆菌学组/幽门螺杆菌科研协作组.第三次全国幽门螺杆菌感染若干问题共识报告.胃肠病学,2008;13(1):42-46
[44]谢维宁,彭志允,乔娜丽.沈英森教授治疗脾胃病经验介绍.新中医,2007;39(2):9-10
[45]李胜.辨证治疗抗生素所致脾胃病4例举隅.中医药学刊,2001;19:358
[46]李本华,宋鹰.辨证治疗应用抗生素后胃肠道反应.现代医药卫生,2005;21(7):850
[47]李刚.分型辨治抗生素所致小儿脾胃功能下降120例.四川中医,2002;20(3):58-59
[48]石小平,李丽华.应用抗生素后出现脾虚湿盛证的护理.湖北中医杂志,2002;24(5):56
[49]卢美全.埃索美拉唑三联疗法根除幽门螺杆菌疗效观察.医学临床研究,2006;2(12):2025-2026
[50]余祖茂,于岚,陈林.雷贝拉唑与克拉霉素和阿莫西林连用对根除幽门螺杆菌感染的近期疗效.中华临床医学研究杂志,2006;12(14):1940
[51]梁小燕,高青,龚能平等.埃索美拉唑肠溶胶囊治疗幽门螺杆菌疗效观察.中国药房,2007;18(26):2044-2046
[52]郭惠学。周怀力,冯文周等.埃索美拉唑三联疗法对十二指肠球部溃疡及根除幽门螺杆菌的疗效观察.中国医院药学杂志,2007;27(9):1278-1279
[53]张静,丁士刚,林三仁等.幽门螺杆菌根除治疗方案比较.临床荟萃,2006;21(22):1600-1602
[2]林三仁.幽门螺杆菌与胃癌的关系.中华消化杂志,2002;22:302
[3]蔡锦莲,黄明河等.慢性胃痛证幽门螺杆菌感染的观察.中国中西医结合脾胃杂志,2000:8(5):319-320
[4]王立,赵荣莱等.慢性胃炎、消化性溃疡中医证型与幽门螺杆菌的关系.中国中西医结合脾胃杂志,1995;3(1):27-28
[5]危北海.慢性胃炎的诊断.中西医结合杂志,1990:10(5):265
[6]朱慧芳,厉兰娜等.幽门螺杆菌感染与慢性胃炎215例临床分析.中国中西医结合脾胃杂志,1996;4(4):244
[7]朱宁,张万岱等.脾虚证各型患者与幽门螺杆菌感染情况的检测.中国中西医结合脾胃杂志,1995;3(2):70-71
[8]张琳,杨连文等.幽门螺杆菌与慢性萎缩性胃炎发病关系及防治研究.中国中西医结合杂志,1992;12(9):521
[9]陈云芝,项柏康等.胃乐汤治疗慢性胃病伴幽门螺杆菌感染的疗效观察.新中医,1995:27(9):21
[10]邓世荣.槟榔治疗幽门螺杆菌感染的临床观察.中医杂志,1993;34(10):605
[11]王绪霖,缴稳玲等.抑制幽门螺旋菌中药的初步筛选.中国中西医结合杂志,1994:14(9):534-536
[12]吴静,王克霞.中药制剂体外抑杀幽门螺杆菌的研究进展.时珍国医国药,2006;17(4):632
[13]朱传伟,朱鸿铭.鲁胃方治疗幽门螺杆菌相关性胃炎37例.山东中医杂志,1997;16(5):208
[14]简军.半夏泻心汤治疗幽门螺杆菌相关性胃炎60例.河南中医,2005;25(1):18
[15]王美林.黄连清胃汤治疗幽门螺杆菌相关性胃炎临床观察.中医药学刊,2005;23(8):1539
[16]李贵贤,陈国忠等.健胃口服液治疗幽门螺杆菌相关性胃炎临床观察.中国中西医结合消化杂志,2004;12(5):274-275
[17]白光.清幽汤加味治疗幽门螺杆菌相关性胃炎临床观察.辽宁中医杂志,2005;32(1):42
[18]郑学宝,尚文燔.疏肝健脾法治疗幽门螺杆菌相关性胃炎44例临床观察.新中医, 1999:31(6):14
[19]姚洁明,卫利平.60例幽门螺杆菌相关性胃炎的疗效分析.上海中医药杂志,1992:2(11):15-16
[20]吴演,柴可夫等.清热益胃汤治疗幽门螺杆菌相关性胃炎31例.浙江中医杂志,1990:26(10):440
[21]曹勤,孙钰等.肠胃清抗幽门螺杆菌感染的临床前瞻性研究.中华消化杂志,2000:20(1):70
[22]姜国平,盛建文等.安中饮治疗幽门螺杆菌相关性胃炎30例.世界华人消化杂志,2004:12(12):2919
[23]王丙信,李进银等.中西医结合治疗幽门螺杆菌相关胃炎81例.中国中西医结合脾胃杂志,1998;6(4):215-216
[24]姚希贤,蒋树林.灭幽门螺杆菌胶囊结合低剂量标准三联法治疗慢性胃炎作用的研究.中国中西医结合脾胃杂志,1997;5(3):131-133
[25]刘汶,王斌等.铋剂与中药二联治疗慢性浅表性胃炎并幽门螺杆菌感染.中国中西医结合脾胃杂志,1999;7(2):102
[26]汪红兵,张声生等.健脾清化法联合西药治疗幽门螺杆菌相关性胃炎34例.中国中西医结合消化杂志,2006;14(6):390
[27]张万怠,徐智民等.幽门螺杆菌研究的现状与展望.中国中西医结合消化杂志,2001:9(6):375。
[28]Alm RA,et al.Genome-sequence comparison of two unrelated isolates of the human gastric pathogen Helicobacter pylori[J].Nature,1999;397:176-180
[29]胡品津,胡伏莲.中华医学会第四次全国幽门螺杆菌学术会议纪要.中华消化杂志,2005:25(11):698
[30]Xiang ZY,Censini S,Bayeli PF,Telford JL,Figura N,Rappuole R et al.Analysis of expression of CagA and VacA virulence factors in 43 strains of Helicobacter pylori reveals that clinical isolates can be divided into two major types and that CagA is not necessary for expression of the vacuolating cytotoxin[J].Infect Immun,1995;63(1):94-98
[31]姚希贤.治疗幽门螺杆菌的研究进展.新消化病学杂志,1999;10(5):267-268
[32]单蕴,许树长,叶元康.幽门螺杆菌抗生素耐药率分析.同济大学学报(医学版),2004:25(1):30-32
[33]陈翠萍,关于幽门螺杆菌疫苗及其相关性研究的报告.微生物学与免疫学进展,2003:31(4):91-93
[34]危北海.近年来消化系统疾病若干问题研究进展及其对中医、中西医结合的挑战 和启示.中华消化杂志,2000;20(4):221
[35]常可敏.中西医综合治疗幽门螺杆菌相关性胃炎106例临床观察.实用中西医结合杂志,1998;11(6):527
[36]王胜功,周玉中.中西医结合治疗慢性胃炎疗效观察.河北中医,2000;22(7):537-538
[37]胡伏莲.幽门螺杆菌感染与上胃肠道疾病.临床内科杂志,2003;20(2):57-59
[38]中华医学会消化病学分会.幽门螺杆菌若干问题的共识意见.中华消化杂志,2000:20(2):117-118
[39]李瑜元.慢性胃炎病因学的新进展.新医学,1998;29(5):230
[40]刘炯.幽门螺杆菌基因组及基因多态性与疾病.见:刘文忠主编.幽门螺杆菌研究进展.上海:上海科学技术文献出版社,2001:1-29
[41]张静,丁士刚,林三仁等.幽门螺杆菌根除治疗方案比较.临床荟萃,2006;21(22):1600
[42]李平,张军会,周华等.蜂胶左金胃三联治疗幽门螺杆菌相关性胃炎的临床研究.云南中医学院学报,2006;29(4):17-18
[43]中华医学会消化病学分会 幽门螺杆菌学组/幽门螺杆菌科研协作组.第三次全国幽门螺杆菌感染若干问题共识报告.胃肠病学,2008;13(1):42-46
[44]谢维宁,彭志允,乔娜丽.沈英森教授治疗脾胃病经验介绍.新中医,2007;39(2):9-10
[45]李胜.辨证治疗抗生素所致脾胃病4例举隅.中医药学刊,2001;19:358
[46]李本华,宋鹰.辨证治疗应用抗生素后胃肠道反应.现代医药卫生,2005;21(7):850
[47]李刚.分型辨治抗生素所致小儿脾胃功能下降120例.四川中医,2002;20(3):58-59
[48]石小平,李丽华.应用抗生素后出现脾虚湿盛证的护理.湖北中医杂志,2002;24(5):56
[49]卢美全.埃索美拉唑三联疗法根除幽门螺杆菌疗效观察.医学临床研究,2006;2(12):2025-2026
[50]余祖茂,于岚,陈林.雷贝拉唑与克拉霉素和阿莫西林连用对根除幽门螺杆菌感染的近期疗效.中华临床医学研究杂志,2006;12(14):1940
[51]梁小燕,高青,龚能平等.埃索美拉唑肠溶胶囊治疗幽门螺杆菌疗效观察.中国药房,2007;18(26):2044-2046
[52]郭惠学。周怀力,冯文周等.埃索美拉唑三联疗法对十二指肠球部溃疡及根除幽门螺杆菌的疗效观察.中国医院药学杂志,2007;27(9):1278-1279
[53]张静,丁士刚,林三仁等.幽门螺杆菌根除治疗方案比较.临床荟萃,2006;21(22):1600-1602